Yuebo Huang

822 total citations
14 papers, 587 citations indexed

About

Yuebo Huang is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuebo Huang has authored 14 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Nephrology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuebo Huang's work include Chronic Kidney Disease and Diabetes (6 papers), Ferroptosis and cancer prognosis (4 papers) and Autophagy in Disease and Therapy (3 papers). Yuebo Huang is often cited by papers focused on Chronic Kidney Disease and Diabetes (6 papers), Ferroptosis and cancer prognosis (4 papers) and Autophagy in Disease and Therapy (3 papers). Yuebo Huang collaborates with scholars based in China and United States. Yuebo Huang's co-authors include Ling Jiang, Yonggui Wu, Xue‐qi Liu, Han-xu Zeng, Li Gao, Xiao‐Ming Meng, Xiangming Qi, Xian Wang, Wei Zhu and Xian Wang and has published in prestigious journals such as Journal of Ethnopharmacology, Molecular Therapy and Frontiers in Pharmacology.

In The Last Decade

Yuebo Huang

14 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuebo Huang China 12 315 154 151 123 87 14 587
Anmei Shu China 9 211 0.7× 83 0.5× 61 0.4× 67 0.5× 44 0.5× 13 402
Jiawei Shang China 12 379 1.2× 275 1.8× 262 1.7× 27 0.2× 92 1.1× 24 684
Bingbing Zhu China 14 238 0.8× 53 0.3× 50 0.3× 137 1.1× 31 0.4× 50 609
Yunxia Du China 13 365 1.2× 66 0.4× 57 0.4× 122 1.0× 110 1.3× 30 601
Zhansheng Hu China 10 204 0.6× 94 0.6× 64 0.4× 29 0.2× 82 0.9× 22 393
Jiamei Lu China 13 264 0.8× 125 0.8× 45 0.3× 55 0.4× 89 1.0× 24 542
Junqi Chen China 13 229 0.7× 39 0.3× 46 0.3× 185 1.5× 70 0.8× 26 570
Ningning Liang China 9 185 0.6× 63 0.4× 66 0.4× 66 0.5× 28 0.3× 13 380

Countries citing papers authored by Yuebo Huang

Since Specialization
Citations

This map shows the geographic impact of Yuebo Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuebo Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuebo Huang more than expected).

Fields of papers citing papers by Yuebo Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuebo Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuebo Huang. The network helps show where Yuebo Huang may publish in the future.

Co-authorship network of co-authors of Yuebo Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuebo Huang. A scholar is included among the top collaborators of Yuebo Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuebo Huang. Yuebo Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wu, Lingzhi, Hongchun Lin, Shaomin Li, et al.. (2024). Macrophage iron dyshomeostasis promotes aging‐related renal fibrosis. Aging Cell. 23(11). e14275–e14275. 23 indexed citations
2.
Liu, Xueqi, Mengya Zhang, Lang Zhou, et al.. (2023). Paeoniflorin alleviates ischemia/reperfusion induced acute kidney injury by inhibiting Slc7a11-mediated ferroptosis. International Immunopharmacology. 116. 109754–109754. 32 indexed citations
3.
Gao, Li, Jun‐Sheng Zhang, Tingting Yang, et al.. (2023). STING/ACSL4 axis-dependent ferroptosis and inflammation promote hypertension-associated chronic kidney disease. Molecular Therapy. 31(10). 3084–3103. 76 indexed citations
4.
Zhang, Mengya, Ling Jiang, Li Gao, et al.. (2023). Paeoniflorin protects against cisplatin-induced acute kidney injury through targeting Hsp90AA1-Akt protein-protein interaction. Journal of Ethnopharmacology. 310. 116422–116422. 29 indexed citations
5.
Li, Yuanyuan, Xueqi Liu, Shanshan Guo, et al.. (2023). Carnosine alleviates kidney tubular epithelial injury by targeting NRF2 mediated ferroptosis in diabetic nephropathy. Amino Acids. 55(9). 1141–1155. 15 indexed citations
6.
Zhen, Xin, Yuxiang Sun, Hongchun Lin, et al.. (2023). Elucidating the role of nicotinamide N-methyltransferase-p53 axis in the progression of chronic kidney disease. PeerJ. 11. e16301–e16301. 3 indexed citations
7.
Jiang, Ling, Xue‐qi Liu, Li Gao, et al.. (2022). METTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy. Molecular Therapy. 30(4). 1721–1740. 135 indexed citations
8.
Huang, Yuebo, Ling Jiang, Xue‐qi Liu, et al.. (2022). Melatonin Alleviates Acute Kidney Injury by Inhibiting NRF2/Slc7a11 Axis‐Mediated Ferroptosis. Oxidative Medicine and Cellular Longevity. 2022(1). 4776243–4776243. 51 indexed citations
9.
Wang, Xian, Ling Jiang, Xue‐qi Liu, et al.. (2022). Paeoniflorin binds to VEGFR2 to restore autophagy and inhibit apoptosis for podocyte protection in diabetic kidney disease through PI3K-AKT signaling pathway. Phytomedicine. 106. 154400–154400. 46 indexed citations
10.
Wang, Xian, et al.. (2022). Clinical Significance of Glomerular Autophagy in Evaluation of Diabetic Kidney Disease Progression. Diabetes Metabolic Syndrome and Obesity. Volume 15. 1945–1959. 9 indexed citations
11.
Wang, Xian, Xue‐qi Liu, Ling Jiang, et al.. (2022). Paeoniflorin directly binds to TNFR1 to regulate podocyte necroptosis in diabetic kidney disease. Frontiers in Pharmacology. 13. 966645–966645. 20 indexed citations
12.
Liu, Xue‐qi, Mingming Liu, Ling Jiang, et al.. (2022). A novel small molecule Hsp90 inhibitor, C-316-1, attenuates acute kidney injury by suppressing RIPK1-mediated inflammation and necroptosis. International Immunopharmacology. 108. 108849–108849. 22 indexed citations
13.
Wang, Xian, Ling Jiang, Xue‐Qi Liu, et al.. (2022). Identification of Genes Reveals the Mechanism of Cell Ferroptosis in Diabetic Nephropathy. Frontiers in Physiology. 13. 890566–890566. 16 indexed citations
14.
Liu, Xue‐qi, Ling Jiang, Yuanyuan Li, et al.. (2021). Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease. Acta Pharmacologica Sinica. 43(1). 96–110. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026